L005 (Divalproex sodium delayed-release 125 mg)

Pill imprint L005 has been identified as Divalproex sodium delayed-release 125 mg.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release

Imprint:

L005

Strength:

125 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Manufacturer:

Lupin Pharmaceuticals, Inc

National Drug Code (NDC):

68180-0265

Inactive Ingredients:

microcrystalline cellulose
D&C Red No. 30
FD&C Blue No. 2
ferric oxide yellow
ferrosoferric oxide
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
hypromellose phthalate (24% phthalate, 55 cst)
hypromelloses
magnesium stearate
propylene glycol
shellac
silicon dioxide
pregelatinized corn starch
magnesium silicate
titanium dioxide
triethyl citrate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.